Fiera Capital Corp Albireo Pharma, Inc. Transaction History

Fiera Capital Corp

  • $32.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$18.01 - $23.78 $42,809 - $56,525
-2,377 Reduced 1.85%
126,109 $2.73 Million
Q3 2022

Nov 03, 2022
BUY
$16.32 - $26.37 $1.23 Million - $1.98 Million
75,088 Added 140.62%
128,486 $1.64 Million
Q2 2022

Aug 10, 2022
BUY
$18.54 - $37.29 $989,998 - $1.99 Million
53,398 New
53,398 $1.06 Million

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email